Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors.
Zhu C, Liu C, Wu Q, Sheng T, Zhou R, Ren E, Zhang R, Zhao Z, Shi J, Shen X, Sun Z, Mao Z, He K, Zhang L, Ding Y, Gu Z, Wang W, Li H.
Zhu C, et al. Among authors: zhou r.
Signal Transduct Target Ther. 2024 Nov 22;9(1):307. doi: 10.1038/s41392-024-02028-3.
Signal Transduct Target Ther. 2024.
PMID: 39572541